Alyeska Investment Group
AVNR

Alyeska Investment Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Alyeska Investment Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-553,190
Closed -$9.38M – 669
2014
Q4 		$9.38M Buy
553,190
+253,190
+84% +$3.56M 0.16% 212
2014
Q3 		$3.58M Buy
300,000
+21,682
+8% +$148K 0.07% 254
2014
Q2 		$1.57M Buy
+278,318
New +$1.28M 0.03% 327

Alyeska Investment Group's AVNR Position: Q1 2015 in Review

Alyeska Investment Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 553,190 shares — an estimated $9.38M sold.

Alyeska Investment Group first reported a position in AVNR in Q2 2014 and held it in 3 quarters. The position peaked at $9.38M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Alyeska Investment Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 553,190 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $9.38M.
  • Alyeska Investment Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2014 and held it in 3 quarters.
  • Alyeska Investment Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $9.38M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Alyeska Investment Group's 13F filing for Q1 2015, filed 15 May 2015.